Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « David Devos »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
David Burn < David Devos < David Grabli  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000047 (2014) Nicolas Carriere [France] ; Pierre Besson ; Kathy Dujardin ; Alain Duhamel ; Luc Defebvre [France] ; Christine Delmaire ; David DevosApathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis.
000080 (2013) Georg Ebersbach [Allemagne] ; Caroline Moreau ; Florin Gandor ; Luc Defebvre [France] ; David DevosClinical syndromes: Parkinsonian gait.
000155 (2011) Ellis Chan [France] ; Perrine Charles [France] ; Pascale Ribai [France] ; Cyril Goizet [France] ; Cecilia Marelli [France] ; Carlo-Maria Vincitorio [France] ; Alice Le Bayon [France] ; Lucie Guyant-Maréchal [France] ; Nadia Vandenberghe [France] ; Mathieu Anheim [France] ; David Devos [France] ; Leorah Freeman [France] ; Isabelle Le Ber [France] ; Karine N'Guyen [France] ; Maya Tchikviladzé [France] ; Pierre Labauge [France] ; Didier Hannequin [France] ; Alexis Brice [France] ; Alexandra Durr [France] ; Sophie Tezenas Du Montcel [France]Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxias
000235 (2009) Caroline Moreau [France] ; Luc Defebvre [France] ; David Devos [France] ; Fabio Marchetti [Italie] ; Alain Destée [France] ; Alessandro Stefani [Italie] ; Antonella Peppe [Italie]STN versus PPN‐DBS for alleviating freezing of gait: Toward a frequency modulation approach?
000240 (2009) David Devos [France]Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease
000264 (2009) Dominique Caparros-Lefebvre [France] ; Olivier Kerdraon [France] ; David Devos [France] ; C. M. Dhaenens [France] ; David Blum [France] ; C. A Maurage [France] ; André Delacourte [France] ; Bernard Sablonnière [France]Association of corticobasal degeneration and Huntington's disease: Can Tau aggregates protect Huntingtin toxicity?
000278 (2008) Cyril Gitiaux [France] ; Emmanuel Roze [France] ; Kiyoka Kinugawa [France] ; Constance Flamand-Rouvière [France] ; Nathalie Boddaert [France] ; Emmanuelle Apartis [France] ; Vassili Valayannopoulos [France] ; Guy Touati [France] ; Jacques Motte [France] ; David Devos [France] ; Karine Mention [France] ; Dries Dobbelaere [France] ; Diana Rodriguez [France] ; Agathe Roubertie [France] ; Brigitte Chabrol [France] ; François Feillet [France] ; Marie Vidailhet [France] ; Nadia Bahi-Buisson [France]Spectrum of movement disorders associated with glutaric aciduria type 1: A study of 16 patients
000284 (2008) Amir Glik [Israël] ; Isabelle Vuillaume [France] ; David Devos [France] ; Rivka Inzelberg [Israël]Psychosis, short stature in benign hereditary chorea: A novel thyroid transcription factor‐1 mutation
000293 (2008) Agnès Annic [France] ; David Devos [France] ; Alain Destée [France] ; Luc Defebvre [France] ; Arnaud Lacour [France] ; Jean-François Hurtevent [France] ; Tanya Stojkovic [France]Early dopasensitive Parkinsonism related to myotonic dystrophy type 2
000298 (2008) David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France]Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study
000347 (2007) Kathy Dujardin [France] ; Pascal Sockeel [France] ; David Devos [France] ; Marie Delliaux [France] ; Pierre Krystkowiak [France] ; Alain Destée [France] ; Luc Defebvre [France]Characteristics of apathy in Parkinson's disease
000359 (2006) David Devos [France] ; Isabelle Vuillaume [France] ; Alix De Becdelievre [France] ; Berengère De Martinville [France] ; Claire-Marie Dhaenens [France] ; Jean-Christophe Cuvellier [France] ; Jean-Marie Cuisset [France] ; Louis Vallée [France] ; Marie-Pierre Lemaitre [France] ; Hélène Bourteel [France] ; Eric Hachulla [France] ; Benoit Wallaert [France] ; Alain Destée [France] ; Luc Defebvre [France] ; Bernard Sablonnière [France]New syndromic form of benign hereditary chorea is associated with a deletion of TITF‐1 and PAX‐9 contiguous genes
000531 (2000) David Devos [France] ; Luc Defebvre [France] ; Alain Destée [France] ; Jacques Caron [France]Choreic movements induced by cibenzoline: An Ic class antiarrhythmic effect?

List of associated KwdEn.i

Nombre de
documents
Descripteur
13Humans
10Female
9Male
7Aged
7Nervous system diseases
5Middle Aged
4Adult
4Parkinson Disease (complications)
3Chorea
3Parkinson Disease (psychology)
3Parkinson disease
2Antiparkinson Agents (therapeutic use)
2Apathy
2Child
2Child, Preschool
2Chorea (genetics)
2Depression
2Dystonia
2Family Health
2Gait Disorders, Neurologic (etiology)
2Human
2Lung
2Lung Diseases (etiology)
2Magnetic Resonance Imaging
2Nuclear Proteins (genetics)
2Parkinson Disease (drug therapy)
2Parkinson's disease
2Prevalence
2Retrospective Studies
2Thyroid gland
2Transcription Factors (genetics)
2Treatment
2Young Adult
2benign hereditary chorea
2depression
1Accidental Falls
1Aciduria
1Adolescent
1Advanced stage
1Age Factors
1Aged, 80 and over
1Analysis of Variance
1Anti-Arrhythmia Agents (adverse effects)
1Antiarrhythmic agent
1Antidepressive Agents (adverse effects)
1Antidepressive Agents (therapeutic use)
1Antiparkinson Agents (adverse effects)
1Arrhythmia
1Arrhythmias, Cardiac (drug therapy)
1Atrophy (pathology)
1Basal Ganglia (pathology)
1Basal ganglion
1Behavior
1Biomechanical Phenomena
1Brain (pathology)
1Case study
1Cerebellar ataxia
1Cerebellum (pathology)
1Cerebellum (physiopathology)
1Cerebral Cortex (pathology)
1Chemotherapy
1Chorea (chemically induced)
1Chorea (complications)
1Chorea (physiopathology)
1Chromosomes, Human, Pair 14
1Cibenzoline
1Citalopram
1Citalopram (adverse effects)
1Citalopram (therapeutic use)
1Codon, Terminator (genetics)
1Cognition Disorders (etiology)
1Comparative study
1Complication
1DNA Mutational Analysis
1Deep Brain Stimulation
1Deletion
1Dementia (drug therapy)
1Dementia (etiology)
1Depression (drug therapy)
1Depression (epidemiology)
1Depression (etiology)
1Depression (psychology)
1Desipramine
1Desipramine (adverse effects)
1Desipramine (therapeutic use)
1Diagnosis, Differential
1Disability Evaluation
1Disease Progression
1Dopamine (metabolism)
1Dopamine Agents (therapeutic use)
1Dopamine Antagonists (adverse effects)
1Double blind study
1Double-Blind Method
1Duodenum
1Duodenum (physiology)
1Duodopa
1Dyskinesia, Drug-Induced (physiopathology)
1Dystonia (chemically induced)
1Elderly
1Electrodes, Implanted

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "David Devos" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "David Devos" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    David Devos
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024